Trek Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Trek Financial's NVO Position: Q2 2026 in Review
Trek Financial increased its Novo Nordisk (NVO) stake by 27% in Q2 2026, buying an estimated $97.6K and bringing the position to 10,744 shares worth $515K. The position accounts for 0.03% of the portfolio, ranked #328.
Trek Financial first reported a position in NVO in Q2 2024 and has held it in 7 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Trek Financial held 10,744 shares of Novo Nordisk worth $515K as of Q2 2026.
- Trek Financial bought 2,271 Novo Nordisk shares in Q2 2026, an estimated $97.6K.
- Novo Nordisk made up 0.03% of Trek Financial's portfolio in Q2 2026, its #328 holding.
- Trek Financial first reported a position in Novo Nordisk in Q2 2024 and has held it in 7 quarters since.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.